Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28453692

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2017 May 1
First author
Ott PA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2017 Oct 1;28(10):2620. doi: 10.1093/annonc/mdx291.
    note
    Source null
    related pmid
    28945890
    relationship
    Comment in
  2. citation
    Transl Gastroenterol Hepatol. 2019 Aug 19;4:57. doi: 10.21037/tgh.2019.08.02.
    note
    Source null
    related pmid
    31559338
    relationship
    Comment in

Authors and identifiers

  1. name
    Ott PA
    type
    Author
  2. name
    Piha-Paul SA
    type
    Author
  3. name
    Munster P
    type
    Author
  4. name
    Pishvaian MJ
    type
    Author
  5. name
    van Brummelen EMJ
    type
    Author
  6. name
    Cohen RB
    type
    Author
  7. name
    Gomez-Roca C
    type
    Author
  8. name
    Ejadi S
    type
    Author
  9. name
    Stein M
    type
    Author
  10. name
    Chan E
    type
    Author
  11. name
    Simonelli M
    type
    Author
  12. name
    Morosky A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ott PA
    type
    Author
  2. name
    Piha-Paul SA
    type
    Author
  3. name
    Munster P
    type
    Author
  4. name
    Pishvaian MJ
    type
    Author
  5. name
    van Brummelen EMJ
    type
    Author
  6. name
    Cohen RB
    type
    Author
  7. name
    Gomez-Roca C
    type
    Author
  8. name
    Ejadi S
    type
    Author
  9. name
    Stein M
    type
    Author
  10. name
    Chan E
    type
    Author
  11. name
    Simonelli M
    type
    Author
  12. name
    Morosky A
    type
    Author
bibliography ids
  1. nci-bib-8f3a76f9058b2b2a1b221e85
book metadata
content sha256
c2c0dbac2f22f52119dfc77ac0c36e1c8d3837d98bdff9112985beebb7a4fa30
document type
citation
dois
  1. 10.1093/annonc/mdx029
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:28453692
immutable id
pubmed:28453692@c2c0dbac2f22f52119dfc77ac0c36e1c8d3837d98bdff9112985beebb7a4fa30
journal
abbreviation
Ann Oncol
issn electronic
1569-8041
issn print
0923-7534
issue
5
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
1036-1041
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2017 Oct 1;28(10):2620. doi: 10.1093/annonc/mdx291.
    note
    Source null
    related pmid
    28945890
    relationship
    Comment in
  2. citation
    Transl Gastroenterol Hepatol. 2019 Aug 19;4:57. doi: 10.21037/tgh.2019.08.02.
    note
    Source null
    related pmid
    31559338
    relationship
    Comment in
outcomes validated
false
pmid
28453692
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
b9cfa96c1555e3a0667d013ba6501e6a36bdcab90edfc8859452bf4e7491a74e
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 May 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28453692/
title
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.

Preserved source evidence · Not medical advice